CEQUA Drug Patent Profile

✉ Email this page to a colleague

Which patents cover Cequa, and what generic alternatives are available?

Cequa is a drug marketed by Sun Pharm and is included in one NDA. There are five patents protecting this drug.

This drug has thirty-six patent family members in twenty-four countries.

The generic ingredient in CEQUA is cyclosporine. There are eighteen drug master file entries for this compound. Nineteen suppliers are listed for this compound. Additional details are available on the cyclosporine profile page.

DrugPatentWatch^® Litigation and Generic Entry Outlook for Cequa

A generic version of CEQUA was approved as cyclosporine by HIKMA on October 29^th, 1999.

Sign Up

AI Research Assistant

Questions you can ask:

What is the 5 year forecast for CEQUA?
What are the global sales for CEQUA?
What is Average Wholesale Price for CEQUA?

Summary for CEQUA

International Patents:	36
US Patents:	5
Applicants:	1
NDAs:	1
Finished Product Suppliers / Packagers:	1
Raw Ingredient (Bulk) Api Vendors:	89
Patent Applications:	4,377
Drug Prices:	Drug price information for CEQUA
Patent Litigation and PTAB cases:	See patent lawsuits and PTAB cases for CEQUA
What excipients (inactive ingredients) are in CEQUA?	CEQUA excipients list
DailyMed Link:	CEQUA at DailyMed

Drug patent expirations by year for CEQUA

Pharmacology for CEQUA

Drug Class	Calcineurin Inhibitor Immunosuppressant
Mechanism of Action	Calcineurin Inhibitors Cytochrome P450 3A4 Inhibitors P-Glycoprotein Inhibitors

US Patents and Regulatory Information for CEQUA

CEQUA is protected by five US patents.

Patents protecting CEQUA

Patent Number: ⤷ Sign Up
Patent Expiration: ⤷ Sign Up

Topical cyclosporine-containing formulations and uses thereof
Patent Number: ⤷ Sign Up
Patent Expiration: ⤷ Sign Up

Patent Number: ⤷ Sign Up
Patent Expiration: ⤷ Sign Up
Patented Use: INCREASE TEAR PRODUCTION IN PATIENTS WITH KERATOCONJUNCTIVITIS SICCA (DRY EYE).

Topical aqueous nanomicellar, ophthalmic solutions and uses thereof
Patent Number: ⤷ Sign Up
Patent Expiration: ⤷ Sign Up
Patented Use: INCREASE TEAR PRODUCTION IN PATIENTS WITH KERATOCONJUNCTIVITIS SICCA (DRY EYE).

Topical formulations and uses thereof
Patent Number: ⤷ Sign Up
Patent Expiration: ⤷ Sign Up
Patented Use: INCREASE TEAR PRODUCTION IN PATIENTS WITH KERATOCONJUNCTIVITIS SICCA (DRY EYE).

+ Get email alerts for changes to this table

Glossary

Subscribe to access the full database, or Sign Up
Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	TE	Type	RLD	RS	Patent No.	Patent Expiration	Product	Substance	Delist Req.	Exclusivity Expiration
Sun Pharm	CEQUA	cyclosporine	SOLUTION;OPHTHALMIC	210913-001	Aug 14, 2018		RX	Yes	Yes	⤷ Sign Up	⤷ Sign Up	Y			⤷ Sign Up
Sun Pharm	CEQUA	cyclosporine	SOLUTION;OPHTHALMIC	210913-001	Aug 14, 2018		RX	Yes	Yes	⤷ Sign Up	⤷ Sign Up	Y			⤷ Sign Up
Sun Pharm	CEQUA	cyclosporine	SOLUTION;OPHTHALMIC	210913-001	Aug 14, 2018		RX	Yes	Yes	⤷ Sign Up	⤷ Sign Up	Y			⤷ Sign Up
Sun Pharm	CEQUA	cyclosporine	SOLUTION;OPHTHALMIC	210913-001	Aug 14, 2018		RX	Yes	Yes	⤷ Sign Up	⤷ Sign Up				⤷ Sign Up
Sun Pharm	CEQUA	cyclosporine	SOLUTION;OPHTHALMIC	210913-001	Aug 14, 2018		RX	Yes	Yes	⤷ Sign Up	⤷ Sign Up	Y			⤷ Sign Up
>Applicant	>Tradename	>Generic Name	>Dosage	>NDA	>Approval Date	>TE	>Type	>RLD	>RS	>Patent No.	>Patent Expiration	>Product	>Substance	>Delist Req.	>Exclusivity Expiration

International Patents for CEQUA

See the table below for patents covering CEQUA around the world.

Subscribe to access the full database, or Sign Up
Country	Patent Number	Title	Estimated Expiration
Slovenia	2887923		⤷ Sign Up
Finland	2887923		⤷ Sign Up
Russian Federation	2747455	ЦИКЛОСПОРИН-СОДЕРЖАЩИЕ ЛЕКАРСТВЕННЫЕ ФОРМЫ ДЛЯ НАРУЖНОГО ПРИМЕНЕНИЯ И ИХ ПРИМЕНЕНИЯ (MEDICINAL FORMS FOR EXTERNAL USE CONTAINING CYCLOSPORINE AND USE THEREOF)	⤷ Sign Up
Russian Federation	2019130403	ЦИКЛОСПОРИН-СОДЕРЖАЩИЕ ЛЕКАРСТВЕННЫЕ ФОРМЫ ДЛЯ НАРУЖНОГО ПРИМЕНЕНИЯ И ИХ ПРИМЕНЕНИЯ	⤷ Sign Up
Mexico	361858	FORMULACIÓN OFTÁLMICA DE LÍPIDO POLIOXILO O DE ÁCIDO GRASO POLIOXILO Y TRATAMIENTO DE PADECIMIENTOS OCULARES. (OPHTHALMIC FORMULATION OF POLYOXYL LIPID OR POLYOXYL FATTY ACID AND TREATMENT OF OCULAR CONDITIONS.)	⤷ Sign Up
Poland	2887923		⤷ Sign Up
>Country	>Patent Number	>Title	>Estimated Expiration

Supplementary Protection Certificates for CEQUA

Subscribe to access the full database, or Sign Up
Patent Number	Supplementary Protection Certificate	SPC Country	SPC Expiration	SPC Description
2049079	LUC00006	Luxembourg	⤷ Sign Up	PRODUCT NAME: CYCLOSPORINE (GOUTTES OCULAIRES SOUS FORME D'EMULSION); AUTHORISATION NUMBER AND DATE: EU/1/15/990 20150323
>Patent Number	>Supplementary Protection Certificate	>SPC Country	>SPC Expiration	>SPC Description

AI Research Assistant

Questions you can ask:

Summary for CEQUA

Pharmacology for CEQUA

Patents protecting CEQUA

Make Better Decisions: Try a trial or see plans & pricing